BioSpecifics Technologies Corp. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced total revenue was USD 9.442 million compared to USD 8.168 million a year ago. Operating income was USD 7.320 million compared to USD 5.773 million a year ago. Net income was USD 6.272 million compared to USD 5.043 million a year ago. Basic earnings per share was USD 0.86 compared to USD 0.69 a year ago. Diluted earnings per share was USD 0.85 compared to USD 0.69 a year ago. For the nine months, total revenue was USD 26.424 million compared to USD 23.108 million a year ago. Operating income was USD 19.356 million compared to USD 16.192 million a year ago. Net income was USD 17.115 million compared to USD 13.869 million a year ago. Basic earnings per share was USD 2.34 compared to USD 1.92 a year ago. Diluted earnings per share was USD 2.33 compared to USD 1.89 a year ago.